Empowerment Training on Type 2 Diabetes Patients on Empowerment Levels and Clinical Findings

NCT05680207 | Completed

• 1 other identifier: DM Training
• Study Type: interventional
• Target: 216
• Locations: 1 country
• Sites: 1

Brief Summary

In this study, the effect of nurse-led empowerment training given to patients with Type 2 Diabetes on clinical findings and empowerment behaviors will be investigated.

Conditions

Diabetes Mellitus, Type 2; Empowerment; Patient Empowerment

Outcome Measures

Primary Outcomes (1)

• improvement in The Diabetes Empowerment Scale scores

  The Diabetes Empowerment Scale (DES-28) questionnaires consist of 28 items with 3 subscales, with each item rated along a 5-point Likert scale (1 = strongly disagree, 2 = disagree, 3 = neutral, 4 = agree, 5 = strongly agree). The range of score was divided in three subgroups as low (28-65 scores), middle (66-103) and high (104-140). All items have been scored so that a higher value indicates stronger empowerment.

  3 months

Secondary Outcomes (4)

• improvement in HbA1c levels

  6 months

• improvement in fasting glucose

  6 months

• improvement in low density lipoprotein

  6 months

• improvement in triglyceride

  6 months

Study Arms (2)

Intervention group

ACTIVE COMPARATOR

Type 2 Diabetes Mellitus patients who received a empowerment training program for 6 weeks, 2 hours a week

Behavioral: Diabetes self- management education (DSME) program

Control group

NO INTERVENTION

Type 2 Diabetes Mellitus patients who did not receive a empowerment training program

Interventions

Diabetes self- management education (DSME) program BEHAVIORAL

We offered a two-hour course each week, comprising of two sessions of lectures (40 minutes each), two breaks (10 min each) and interactive session (20 min). In the interactive session, patients could communicate with each other in groups or raise any questions to the investigators.

Intervention group

Eligibility Criteria

• Age: 18 Years - 65 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Patients with Type 2 Diabetes Mellitus diagnosed more than 1 year ago

You may not qualify if:

• Mental retardation
• Dementia
• Deafness
• Blindness
• Psychiatric illness
• Steroid use

Sponsors & Collaborators

• Kutahya Health Sciences University: lead

Study Sites (1)

Acıbadem Hospital

Eskişehir, 26170, Turkey (Türkiye)

Location

Related Publications (1)

• Messina R, Rucci P, Sturt J, Mancini T, Fantini MP. Assessing self-efficacy in type 2 diabetes management: validation of the Italian version of the Diabetes Management Self-Efficacy Scale (IT-DMSES). Health Qual Life Outcomes. 2018 Apr 23;16(1):71. doi: 10.1186/s12955-018-0901-3.

  PMID: 29685153 RESULT

MeSH Terms

Conditions

Diabetes Mellitus, Type 2; Empowerment; Patient Participation

Condition Hierarchy (Ancestors)

Diabetes Mellitus; Glucose Metabolism Disorders; Metabolic Diseases; Nutritional and Metabolic Diseases; Endocrine System Diseases; Social Behavior; Behavior; Patient Acceptance of Health Care; Treatment Adherence and Compliance; Health Behavior

Study Officials

• müzelfe bıyık, Ms

  Eskişehir Osmangazi University

  STUDY CHAIR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Master of Science

Study Record Dates

• First Submitted: December 20, 2022
• First Posted: January 11, 2023
• Study Start: March 1, 2019
• Primary Completion: July 30, 2019
• Study Completion: August 30, 2019
• Last Updated: January 11, 2023

Record last verified: 2023-01

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)